Smarter radiation: could less be more for throat cancer patients?

NCT ID NCT06563362

Recruiting now Disease control Sponsor: University of Zurich Source: ClinicalTrials.gov ↗

First seen Nov 18, 2025 · Last updated May 16, 2026 · Updated 27 times

Summary

This study tests whether giving radiation to fewer lymph nodes in the neck, based on each patient's cancer spread, can reduce side effects without increasing the risk of cancer returning. About 120 adults with newly diagnosed oropharynx cancer will receive standard (chemo)radiotherapy but with a personalized, smaller radiation field. The main goal is to see how many patients develop new lymph node tumors outside the treated area within 2 years.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Cantonal Hospital Aarau
RECRUITING

Aarau, Switzerland

Contact Phone: •••-•••-•••• Email: •••••@•••••
Hôpitaux universitaires de Genève
RECRUITING

Geneva, Switzerland

Contact Phone: •••-•••-•••• Email: •••••@•••••
Inselspital Bern
RECRUITING

Bern, Switzerland

Contact Phone: •••-•••-•••• Email: •••••@•••••
Ospedale Regionale di Bellinzona
RECRUITING

Bellinzona, Switzerland

Contact
Zurich University Hospital
RECRUITING

Zurich, Canton of Zurich, 8091, Switzerland

Contact

Conditions

Explore the condition pages connected to this study.

OROPHARYNX CANCER